Women's Health Weekly — 2026-05-12
A major Cleveland Clinic report reveals a significant knowledge gap among women regarding their elevated Alzheimer's risk, while new research highlights breakthroughs for women over 50 including a landmark type 1 diabetes trial. Workplace menopause policy adoption remains critically low, with only 18% of women reporting their employer has one in place.
Key Highlights
Cleveland Clinic Report Exposes Alzheimer's Knowledge Gap
A new report from the Cleveland Clinic reveals that most women are unaware they face a higher risk of developing Alzheimer's disease than men. Published May 12, the findings point to a critical gap in health literacy that could affect early detection and prevention efforts for millions of women.
Type 1 Diabetes Breakthrough for Women Over 50
A University of Chicago trial is generating significant buzz in women's health research. All 10 initial participants — who had lived with type 1 diabetes for an average of 33 years — achieved nondiabetic bloodwork and full insulin independence within four weeks of treatment. The breakthrough is among several new findings being highlighted this week for women over 50, which also include developments in sleep apnea treatment and new heart health guidance.
Only 18% of Women Have a Workplace Menopause Policy
A new poll from women's health and wellness supplement brand Seren finds that fewer than one in five women (18%) report having a workplace menopause policy at their employer. The survey results, published this week, underscore persistent gaps in workplace support for women navigating menopause and perimenopause.
May is Women's Health Month, and clinicians are using the opportunity to raise awareness that menopause symptoms can affect the body "head to toe," according to UPMC physicians who spoke this week about perimenopause — the often-overlooked transitional stage that precedes menopause.
Women's Health App Market on Track for $18 Billion by 2031
According to a new report from Allied Market Research, the global women's health app market is on a steep growth trajectory, projected to reach $18.25 billion by 2031 at a compound annual growth rate (CAGR) of 20.1%. Drivers include rising smartphone penetration, growing wellness awareness, and increasing demand for digital health tools tailored to women.
Perimenopause Gets Long-Overdue Attention
USA Today published a widely-shared explainer this week on perimenopause — describing it as "the overlooked stage prior to menopause" — noting that understanding what perimenopause is can make a meaningful difference in helping individuals and families navigate the transition. Clinicians emphasize that this stage can last years and is frequently misdiagnosed or dismissed.
Analysis
Why the Alzheimer's-Women's Health Disconnect Matters
The Cleveland Clinic's findings published this week land at a pivotal moment. Women make up approximately two-thirds of all Alzheimer's patients in the United States, yet the report suggests most women don't know this fact — and therefore may not seek early screening or take advantage of emerging preventive care.
This knowledge gap intersects with a broader pattern: menopause, perimenopause, and midlife hormonal transitions have long been underrepresented in medical research and public health education. The AHA's ongoing initiative — Redefining Women's Health: From Heart to Head to Hormones — reflects growing scientific recognition that midlife hormonal changes in women have downstream effects on cognitive and cardiovascular health alike.
The workplace menopause policy data adds another layer. If women can't openly discuss symptoms with employers or access support, the window for intervention — medical, occupational, and educational — narrows. Taken together, the week's findings make a compelling case that systemic change is needed not just in research funding, but in how women are informed and supported throughout midlife.
What to Watch
-
Workplace menopause policy momentum: With only 18% adoption, advocates are pushing for legislation and employer incentives to close the gap. Watch for policy proposals from HR and occupational health organizations in the coming weeks.
-
Women's health app regulation: As the market races toward $18 billion, regulatory bodies have not yet caught up with oversight frameworks for femtech applications. Expect increased scrutiny from the FDA and international equivalents.
-
Type 1 diabetes trial expansion: The University of Chicago trial showing full insulin independence in 10 initial participants will likely move toward larger-scale trials. Women with long-standing type 1 diabetes are a significant portion of the patient population, and this development warrants close follow-up.
-
Cognitive health and menopause research: With Alzheimer's awareness front and center this week, expect more studies linking hormonal transitions to long-term brain health outcomes — a research frontier that the AHA and pharmaceutical funders have flagged as a priority for 2026.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
